BMI Korea Co., Ltd., established in 2005 and headquartered in Jeju, South Korea, is a biopharmaceutical company specializing in the development and manufacturing of advanced drugs and medical devices. With a focus on health and medical innovation, the company provides Contract Development and Manufacturing Organization (CDMO) services, supporting pharmaceutical firms in areas such as research, product development, and clinical trials. BMI Korea operates manufacturing facilities in Jeju and Osong, producing a range of pharmaceutical products, including injectable and oral dosage forms, alongside biologics like recombinant proteins and mRNA-based therapies